Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Syngene International has informed that it enclosed the press release titled ‘Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035’. The above-mentioned press release will also be available on the website of the Company www.syngeneintl.com.
The above information is a part of company’s filings submitted to BSE.